Larimar Therapeutics
LRMR
#8139
Rank
NZ$0.60 B
Marketcap
NZ$5.74
Share price
-2.48%
Change (1 day)
-9.47%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): NZ-$3.38

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.56. In 2025 the company made an earnings per share (EPS) of NZ-$4.04 a decrease over its 2024 EPS that were of NZ-$2.38.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.38-16.33%
2025NZ-$4.0470%
2024NZ-$2.38
2022NZ-$2.82-48.15%
2021NZ-$5.43-14.27%
2020NZ-$6.33